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Background: Generation Scotland: Scottish Family Health Study (GS:SFHS) is a family-based biobank of 24,000
participants with rich phenotype and DNA available for genetic research. This paper describes the laboratory results
from genotyping 32 single nucleotide polymorphisms (SNPs) on DNA from over 10,000 participants who attended
GS:SFHS research clinics. The analysis described here was undertaken to test the quality of genetic information
available to researchers. The success rate of each marker genotyped (call rate), minor allele frequency and
adherence to Mendelian inheritance are presented. The few deviations in marker transmission in the 925
parent-child trios analysed were assessed as to whether they were likely to be miscalled genotypes, data or sample
handling errors, or pedigree inaccuracies including non-paternity.
Methods: The first 10,450 GS:SFHS clinic participants who had spirometry and smoking data available and DNA
extracted were selected. 32 SNPs were assayed, chosen as part of a replication experiment from a Genome-Wide
Association Study meta-analysis of lung function.
Results: In total 325,336 genotypes were returned. The overall project pass rate (32 SNPs on 10,450 samples) was
97.29%. A total of 925 parent-child trios were assessed for transmission of the SNP markers, with 16 trios indicating
evidence of inconsistency in the recorded pedigrees.
Conclusions: The Generation Scotland: Scottish Family Health Study used well-validated study methods and can
produce good quality genetic data, with a low error rate. The GS:SFHS DNA samples are of high quality and the
family groups were recorded and processed with accuracy during collection of the cohort.
Keywords: Genetics, SNP Genotyping, Parent-child trios, Error rate, Non paternity, Generation Scotland, BiobankBackground
Generation Scotland is a multi-institution, cross-discip-
linary collaboration that has created an ethically sound,
family- and population-based resource for identifying the
genetic basis of common complex diseases [1,2]. The Ge-
neration Scotland: Scottish Family Health Study (GS:SFHS)
has DNA and socio-demographic and clinical data from
~24,000 volunteers from across Scotland. The ethnicity of
the cohort is 99% white, with 96% born in the UK, 87% in* Correspondence: shona.kerr@igmm.ed.ac.uk
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reproduction in any medium, provided the orScotland. Specific features of GS:SFHS include the family-
based recruitment, with the intent of obtaining family
groups; breadth and depth of phenotype information; con-
sent and mechanisms for linkage of all data to comprehen-
sive routine healthcare records; “broad” consent from
participants to use their data and samples for a wide range
of medical research, and for re-contact. These features
were designed to maximise the power of the resource to
identify, replicate or control for genetic factors associated
with a wide spectrum of illnesses and risk factors, both
now and in the future [3]. Potential participants were
identified at random from those aged 35–65 years from
the lists of collaborating general medical practices, and in-
vited to participate and to identify at least one first-degree. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[3]. This paper describes analysis of DNA samples from
more than 10,000 of the participants in GS:SFHS for ge-
notyping and pedigree quality. This was undertaken to test
the quality of genotyping, to inform researchers interested
in genetic research using the GS resource.
Methods
Extraction and storage of DNA
All samples from Generation Scotland participants were
collected, processed and stored using standard operating
procedures and managed through a laboratory informa-
tion management system (LIMS). Blood was taken from
consenting participants in GS research clinics using stan-
dard venepuncture procedures and collected in a 9 ml
EDTA tube. Each blood sample was processed for DNA
extraction using a Nucleon Kit (Tepnel Life Science) with
the BACC3 protocol. The precipitated DNA was hooked
out and placed directly into a labelled 2.0 ml microtube
(Scientific Specialities Inc) containing 1 ml TE buffer pH
7.5 (10 mM Tris-Cl pH 7.5, 1 mM EDTA pH 8.0). Postal
participants and clinic participants from whom sufficient
blood was not obtained were invited to provide a sample
of saliva in an Oragene OG-250 saliva kit, for DNA extrac-
tion. DNA was extracted from these into similar micro-
tubes by a standard protocol (DNA Genotek). Microtubes
were rotated for 2 weeks at room temperature until DNA
was fully re-suspended. DNA concentrations (ng/μl) were
determined for all samples using the Picogreen method
(Invitrogen). Eight out of every batch of 92 samples were
electrophoresed on a 1% agarose gel to test for integrity of
the DNA and were all satisfactory, and were also run on a
NanoDrop (Thermo Scientific) to confirm DNA yield and
to determine levels of protein and RNA contamination.
500 μl of each DNA master stock were transferred to a
deep well plate then normalised to 50 ng/μl to make
working stock plates. The remaining 500 μl were archived
in a microtube at −40°C.
Open array genotyping
DNA from the first 10,450 GS:SFHS clinic participants
that had spirometry, smoking data and DNA extracted
was analysed, as part of a replication experiment from a
Genome-Wide Association Study meta-analysis of lung
function [4]. Each plate of DNA held 95 samples, with
one well containing only TE buffer as a no template
control. The OpenArray genotyping system (Applied
Biosystems) uses nanolitre fluidic technology in conjunc-
tion with TaqManW chemistry to enable high-throughput
and low cost workflows. Thirty of the SNPs were pre-
designed ABI assays and two SNPs were custom desig-
ned. After thermal cycling, the OpenArray was imaged
on an OpenArray NT scanner as an end point assay and
genotypes were called using Genotyper Analysis softwarev1.0.1. All SNPs were visually examined for any clus-
tering issues. The OpenArray genotype data was impor-
ted into a MySQL v5.1 database and analysed using SQL
scripts. The results were verified with Pedstats software
within the MERLIN package [5].
Ethical issues
All components of GS:SFHS have received ethical ap-
proval from the NHS Tayside Committee on Medical
Research Ethics (REC Reference Number: 05/S1401/89).
GS:SFHS has been granted Research Tissue Bank status
by the Tayside Committee on Medical Research Ethics
(REC Reference Number: 10/S1402/20) providing gene-




The GS:SFHS DNA samples analysed all passed the rou-
tine quality control tests of intactness and purity de-
scribed in Methods. Yield of DNA was high, with a low
rate of extraction failure. DNA was obtained from over
98% of the 23,960 GS:SFHS participants. Of these, 2.5%
had a total yield of less than 30 μg of genomic DNA,
while the yield of the other 97.5% had an mean of
272 μg and a median of 232 μg. If necessary, at some
future point DNA stocks of low yield samples could
be replenished through the technique of whole gen-
ome amplification [6], or by re-contact and re-sampling of
participants.
SNP genotyping
Thirty-two SNP markers were chosen as part of a fol-
low-up replication experiment from a Genome-Wide
Association Study meta-analysis on lung function, which
has provided insights into genetic causes of chronic pul-
monary disease [4]. The details of the SNPs genotyped
are summarised in Table 1. They lie on eleven different
chromosomes and have minor allele frequencies ranging
from 4.3% to 49.6%, in good or excellent agreement with
rates recorded in populations of European ancestry in
the dbSNP database [7]. There are 27 independent SNPs,
as indicated by superscripts a-d showing the four separ-
ate groups of related markers in Table 1.
29 SNPs out of the 32 SNPs chosen gave analysa-
ble OpenArray data. The three SNPs that failed on the
OpenArray could not be called because individual clus-
ters could not be identified. These SNPs were success-
fully re-run as Taqman assays on the 7900HT platform
(Table 1). Call rates ranged from 91.6% to 99.5% of DNA
samples assayed (Table 1). Within the 10,450 DNA sam-
ples analysed by OpenArray, there were 289 samples de-
rived from saliva, with an average call rate of 96.22%.
Table 1 Summary of SNP markers analysed
dbSNP ID Chr. Major allele Minor allele Minor allele frequency Call rate Method
rs2284746 1 C G 47.7% 91.6% OpenArray
rs993925 1 C T 34.9% 97.6% OpenArray
rs12477314 2 C T 20.2% 97.7% OpenArray
rs2544527 2 C T 35.9% 97.8% OpenArray
rs1344555 3 C T 21.3% 98.0% OpenArray
rs1529672 3 C A 17.8% 98.5% TaqMan
rs9310995 3 T C 43.6% 98.2% OpenArray
rs1541374 4 G T 34.6% 94.1% OpenArray
rs10067603 5 A G 24.3% 96.2% OpenArray
rs1551943 5 G A 23.6% 97.3% OpenArray
rs153916 5 T C 45.8% 97.9% OpenArray
rs2798641 6 C T 17.6% 98.3% OpenArray
rs1928168 6 C T 49.6% 98.3% OpenArray
rs2855812a 6 G T 26.4% 97.1% OpenArray
rs2857595a 6 G A 21.5% 95.4% OpenArray
rs3094548 6 C G 35.2% 97.5% OpenArray
rs3734729 6 A G 4.3% 97.9% OpenArray
rs6903823 6 A G 26.8% 99.4% TaqMan
rs11001819 10 A G 48.9% 97.1% OpenArray
rs7068966b 10 T C 48.5% 98.1% OpenArray
rs1878798b 10 G C 46.2% 96.9% OpenArray
rs1036429 12 C T 21.3% 98.0% OpenArray
rs11172113 12 T C 41.3% 97.6% OpenArray
rs4762767 12 G A 27.5% 97.7% OpenArray
rs12914385c 15 C T 38.6% 97.0% OpenArray
rs2036527c 15 G A 33.8% 97.8% OpenArray
rs8040868c 15 T C 38.9% 96.3% OpenArray
rs2865531 16 A T 40.9% 99.5% TaqMan
rs12447804d 16 C T 23.4% 95.2% OpenArray
rs3743563d 16 C T 23.1% 98.6% OpenArray
rs12716852 16 A G 45.2% 97.5% OpenArray
rs9978142 21 A T 14.2% 97.6% OpenArray
Legend: The table shows the reference SNP (rs) ID number and chromosome location of all markers, minor allele frequency and call rate (number of successful
genotype calls as a percentage of the total samples assayed). The four groups of non-independent SNPs (defined as pair wise linkage disequilibrium r2>0.29) are
indicated by superscripts a-d.
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these had a slightly higher call rate of 97.12%.
Use of family data to check study processes - analysis of
marker transmission in complete trios
There may be occasional sample mix ups in any research
clinic and laboratory, but careful adherence to standard
operating procedures and following good clinical prac-
tice and good laboratory practice should minimise such
errors close to zero. However, the inclusion of family
structures allows some independent verification of howwell the study has been conducted, as the laboratory
performing the genotyping is blinded to the family
structure.
Within the samples analysed, there are many different
and sometimes complex family structures of up to three
generations and with extensive kinship, both near and
distant. The 10,450 GS:SFHS participants genotyped can
be grouped in 3,774 families. The distribution of family
size is shown in Figure 1. The family structure of the
sample set assayed is representative of that in the whole
GS:SFHS cohort of ~24,000 people. The largest family
Families (3774) People (10450)
Figure 1 Family size of genotyped participants.
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24 members, within a complex pedigree. For the pur-
poses of this analysis, the focus was on complete trios
(two parents and a child). The participants genotyped
contained 925 such trios which were not all independ-
ent, instead spread across 576 families with up to six
children (Table 2).
One of the largest families, ID number F289, con-
tained 16 members in three generations, 13 of whom
were genotyped in this study (Figure 2). The three peo-
ple not genotyped are represented by un-shaded symbols
and were not recruited into GS:SFHS, but their existence
is required to draw the pedigree. There are three com-
plete trios within this single pedigree. The genotyping
data for one of the markers that is informative for this
family, rs3094548, are shown. All trios in this family
show inheritance patterns consistent with Mendelian
laws for this and the other 31 markers tested. A possible
total of up to 29,600 genotype results (925 × 32) would
theoretically be available for analysis. After removing un-
determined sample calls, 27,471 results were obtained,
of which the overall parentage statistics show 27,282Table 2 Number of complete trios genotyped within
families of two parents and one or more offspring








Legend: The number of children, families and parent-child trios genotyped
is shown.(99.31%) to be completely consistent with the recorded
pedigrees. The results of the 189 analyses inconsistent
with pedigree, affecting 129 trios, are detailed in Table 3.
Genotype error is a likely explanation for many of the
instances of lack of adherence to expected inheritance,
as 101 of the 129 trios are only inconsistent for one SNP
out of the 32 tested (Table 3). The SNP with the lowest
genotype call rate out of all 32 is rs2284746 (Table 1).
Excluding the genotype data from this SNP reduces the
total number of inconsistent trios to 97, while the 10
most inconsistent trios are unchanged (Table 3). This
analysis was repeated after excluding five non-indepen-
dent SNPs, indicated by the superscripts in Table 1. In
each of the four such sets of SNPs, the marker with the
highest genotyping call rate was retained for analysis,
leaving a total of 27 SNPs, from which rs2284746 was
again removed. This reduced the total number of trios
with inconsistencies to 49, of which 16 had two or
more markers which were not consistent with the re-
corded pedigree.
Discussion
An access process has been defined for Generation
Scotland resources and is fully operational. Family-based
designs for genome-wide association studies are of rene-
wed interest [8]. High density genome-wide genotype
data on 10,000 GS:SFHS DNA samples will soon be gen-
erated, together with whole exome sequencing of DNA
from nearly 1,000 participants. However, it is important
that before resources are committed to such large scale
genotyping or DNA sequencing, family relationships are
verified where possible and quality of the samples is con-
firmed. Confident identification of pedigree errors could
also allow correction of the stored data, thus improving
its accuracy.
This study found high or very high call rates for DNA
from all of the samples tested, and for all of the 32 SNPs
Figure 2 Coloured symbols represent family members who were genotyped, open symbol represents people not recruited into
GS: SFHS. Unique participants IDs allocated for this project are shown under each symbol. Genotyping results for the SNP rs3094548 in family
F289 are shown, with blue reprenting the G allele and red the C allele.
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pedigrees. The 32 SNPs in this analysis were chosen for
a lung function study [4], rather than for pedigree test-
ing, but provide a good range of allele frequencies in this
Northern European population (Table 1), and most are
independent, allowing testing of the recorded family
structures. The relative frequency of the major and mi-
nor alleles is an important determinant of how in-
formative a biallelic SNP assay is in a pedigree. Error
detection rates are lowest when the two alleles have
equal frequencies [9], i.e. there is a higher chance that
any (unrelated) trio would show a genotype consistent
with Mendelian inheritance, despite not actually being
related. Conversely, with a minor allele frequency of
10%, it is more likely that an inheritance discrepancy
would be evident in an incorrect pedigree [10]. Detec-
tion rates are generally lower when the error occurs in aTable 3 Summary of SNP data inconsistent with pedigree





9 1 1 0
8 2 2 2
7 1 1 1
6 0 0 1
4 2 2 2
3 4 4 4
2 18 14 6
1 101 73 33
total 129 97 49
Legend: The number of inconsistent SNPs is given, for three categories of
marker sets.parent than in an offspring [9]. Teo et al [11] described
Nucl3ar software, which assesses the extent of pedigree
inconsistent genotype configurations in the presence of
genotyping errors. This recognised the problem which
was addressed here by analysis using other software as
described.
Any pedigree errors will be unequivocally apparent
with higher throughput data such as GWAS, but the
expected inconsistency rate when a pedigree error is
present with current data would require detailed simula-
tion to calculate, as it depends on allele frequency in the
population, and in the families studied. There are 27
possible genotype configurations for genotype data at a
SNP for the three individuals in a trio, of which 15 are
pedigree consistent and 12 are pedigree inconsistent
(see Teo et al [11] Figure 2 for a summary diagram).
The few inconsistent trios detected here could have
arisen because of errors in pedigree data collection, sam-
ple handling or labelling errors in the clinic or lab, in
the sample selection for genotyping, or genotyping call
errors. Pedigree data was recorded during the volunteer
recruitment process, and has not been independently
verified. Cross-checking with the General Register Office
for Scotland would be laborious and outside the terms
of consent. Participants could also have failed to disclose
adoption, or there could be a different biological father
to that recorded.
Reliable estimates for non-paternity rates are difficult
to establish, with high quoted rates often proving to be
anecdotal [12]. A median rate of paternal discrepancy of
3.7% was reported in a review of 17 populations, studied
for reasons other than disputed paternity [13]. The true
rate may lie closer to 1% in the UK and elsewhere in
Europe [14,15]. The analysis of 925 trios presented here
(Table 3) is unable to unequivocally distinguish the
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consistencies in the father, mother or either parent
apparently occurring at approximately equal frequency.
Consideration of the 16 trios with two or more inde-
pendent SNPs showing inconsistency (Table 3, fourth
column) shows that in 3 of the trios the inconsistency in
the child is not with the genotype of the mother, indi-
cating a maximum estimated non-paternity rate in the
Scottish Family Health Study of less than 1.5% (13 trios
out of 925 analysed). The true rate is likely to be consid-
erably lower, as it is unlikely that all discrepant results
are caused by incorrect pedigrees. These relatively low
rates may in part be due to non-participation in the
study by women who knew the paternity of their child
was uncertain. Participants were informed (in the in-
formation online) that “As part of the Scottish Family
Health Study, researchers will perform tests to check
that family members are genetically related, because this
is essential for the success of the study. The researchers
who carry out these tests will not know, or be able to
find out, the identities of the people who gave the sam-
ples. Generation Scotland will not pass the results of
family testing back to families”. Our study provides a
first estimate of these kinds of errors in the Scottish
Family Health Study. More refined estimates will be ge-
nerated once it is feasible to run genome-wide genotyp-
ing arrays for these samples, as the extensive information
on such arrays will improve both the sensitivity of error
detection and the resolution of genotyping errors from
pedigree inconsistencies. Whilst genome-wide geno-
typing lies outside the scope of the current study, the
wealth of phenotype data available in GS:SFHS mean that
it will prove a rich resource for genome-wide association
studies in the near future.Conclusions
The analyses presented here provide evidence that the
GS:SFHS DNA samples and recorded pedigrees are of
high quality and suitable for genetic analyses. The sys-
tems for collection of family structure data and linkage
of data and samples are fit for purpose.Competing interests
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